NCT04939324Completed
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer
Analyse du Profil moléculaire Des Exosomes de la Veine Pulmonaire Dans le Cancer Bronchique de Stade précoce
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This is an observational prospective single-center study of 30 patients operated for early-staged non-small cell lung cancer. The main aim is the analysis of molecular profiling of exosome with a sample in tumor-draining vein in order to identify prognostic molecular characteristics associated with cancer recurrence after surgery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 31 May 2021
- Start date
- 21 Jun 2021
- Primary completion date
- 25 Jun 2024
- Lead sponsor
- University Hospital, Limoges
- Diseases
- Lung cancer
- NCT number
- NCT04939324
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 21 Jun 2021 to the primary completion date, 25 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Neoadjuvant therapy,
Other illness
- Second cancer or cancer in the 5 years,
Age
- Patients \<18 years-old,
Other
- Pure ground glass nodule,
- Pregnancy,
- Tutorship
Who the study is looking for
- \- Surgical non-small cell lung cancer with pure solid nodule or part-solid ground glass nodule on CT-scan
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Limoges Coordinator of this site? Confirm its status | Limoges | France | Unknown status |
Related publications
- New proteomic signature in circulating extracellular vesicles from tumor-draining and peripheral veins of patients with lung adenocarcinoma.Cancer Cell Int · 2026 · PMID 41923119
This page is information, not medical advice. Discuss any trial with your doctor.